Effect of Transjugular Intrahepatic Portosystemic Shunt Combined with I Particle Implantation on Portal Vein Tumor Thrombus in Hepatocellular Carcinoma

Overview

Journal Am J Transl Res

Specialty General Medicine

Date 2022 Apr 15

PMID 35422930

Authors

Hongbo Han

Yanli Meng

Jitian Wang

Affiliations

Soon will be listed here.

Abstract

Objective: The efficacy of transjugular intrahepatic portosystemic shunt (TIPS) combined with I particle implantation in the treatment of portal vein tumor thrombus (PVTT) in hepatocellular carcinoma was discussed and analyzed in this study.

Methods: A total of 127 patients with primary hepatocellular carcinoma (PHC) complicated with PVTT admitted to our hospital from March 2017 to June 2018 were enrolled. The patients were classified into an observation group (n=69) and a control group (n=58) in the light of the different treatment methods. The control group patients were treated with TIPS alone, and the observation group patients received I particle implantation on the basis of TIPS in the control group. Subsequently, the clinical therapeutic efficacy, perioperative indicators, postoperative complications, quality of life and survival of patients before and after treatment were compared between the two groups.

Results: The remission rate in the observation group was remarkably higher than that of the control group (), and the difference in the overall response rate (ORR) of the two groups of patients was not statistically significant (). The AFP, PLT, WBC and the diameter of the main portal vein in the two groups dropped substantially compared to those before treatment (), and the AFP and the diameter of the main portal vein in the observation group were notably lower than those in the control group (). After treatment, the ALT, AST and TBiL of the two groups were remarkably higher than those before treatment (), and these indicators in the observation group were apparently higher than those in the control group (). There was no significant difference in the incidence of postoperative gastrointestinal bleeding, fever, granulocytopenia and abnormal hepatic dysfunction between the observation group and the control group (). The functional assessment of cancer therapy-hepatobiliary (FACT-Hep) scores of the two groups 6 months after operation was substantially lower than pre-op scores (), and the observation group had apparently lower postoperative scores than the control group (). The progression-free survival (PFS) and overall survival (OS) in the observation group were critically superior to those in the control group ().

Conclusion: TIPS combined with I particle implantation in the treatment of PHC patients with PVTT can help improve patients' clinical treatment efficacy after surgery while prolonging their postoperative survival. The treatment is safe and worthy of clinical promotion.

Citing Articles

Efficacy and safety of transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma-A systematic review and meta-analysis.

Giri S, Singh A, Das S, Strubchevska K, Tripathy T, Patel R Indian J Gastroenterol. 2024; 43(6):1121-1135.

PMID: 39126599 DOI: 10.1007/s12664-024-01646-7.

TIPS for Portal Hypertension in HCC With Tumour Invasion of the Portal Vein Trunk: Anecdote or Promise?.

Bosch J J Clin Exp Hepatol. 2024; 14(2):101356.

PMID: 38389700 PMC: 10879022. DOI: 10.1016/j.jceh.2024.101356.

Transjugular Intrahepatic Portosystemic Shunt for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombus-Related Symptomatic Portal Hypertension.

Xie Y, Lyu T, Song L, Tong X, Wang J, Zou Y J Clin Exp Hepatol. 2023; 14(2):101305.

PMID: 38130294 PMC: 10733097. DOI: 10.1016/j.jceh.2023.101305.

Emergent TIPS for acute gastroesophageal variceal bleeding in cirrhotic patients with hepatocellular carcinoma.

Huang J, Zhong B, Li W, Jiang N, Qian D, Hu Z Abdom Radiol (NY). 2023; 49(3):900-907.

PMID: 38010526 DOI: 10.1007/s00261-023-04088-5.

References

Zhang Z, Lai E, Zhang C, Yu H, Liu Z, Wan B . The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus. Int J Surg. 2015; 20:8-16. DOI: 10.1016/j.ijsu.2015.05.009. View

Sherman C, Behr S, Dodge J, Roberts J, Yao F, Mehta N . Distinguishing Tumor From Bland Portal Vein Thrombus in Liver Transplant Candidates With Hepatocellular Carcinoma: the A-VENA Criteria. Liver Transpl. 2018; 25(2):207-216. PMC: 7103424. DOI: 10.1002/lt.25345. View

Araki K, Harimoto N, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T . Efficiency of regional functional liver volume assessment using Gd-EOB-DTPA-enhanced magnetic resonance imaging for hepatocellular carcinoma with portal vein tumor thrombus. Surg Today. 2020; 50(11):1496-1506. DOI: 10.1007/s00595-020-02062-y. View

Fan W, Yuan G, Fan H, Li F, Wu Y, Zhao Y . Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study. Clin Ther. 2019; 41(8):1463-1476. DOI: 10.1016/j.clinthera.2019.04.036. View

Jiang J, Lao Y, Yuan B, Yin J, Liu X, Chen L . Treatment of hepatocellular carcinoma with portal vein tumor thrombus: advances and challenges. Oncotarget. 2017; 8(20):33911-33921. PMC: 5464922. DOI: 10.18632/oncotarget.15411. View

Chen Z, Lin Z, Chen Y, Chen J, Chen J . Clinical efficacy of endovascular radiofrequency ablation in the treatment of portal vein tumor thrombus of primary hepatocellular carcinoma. J Cancer Res Ther. 2018; 14(1):145-149. DOI: 10.4103/jcrt.JCRT_784_17. View

Gon H, Kido M, Tanaka M, Kinoshita H, Komatsu S, Tsugawa D . Growth velocity of the portal vein tumor thrombus accelerated by its progression, alpha-fetoprotein level, and liver fibrosis stage in patients with hepatocellular carcinoma. Surgery. 2018; 164(5):1014-1022. DOI: 10.1016/j.surg.2018.06.025. View

Cheng S, Yang J, Shen F, Zhou W, Wang Y, Cong W . Multidisciplinary management of hepatocellular carcinoma with portal vein tumor thrombus - Eastern Hepatobiliary Surgical Hospital consensus statement. Oncotarget. 2016; 7(26):40816-40829. PMC: 5130047. DOI: 10.18632/oncotarget.8386. View

Peng S, Wang X, Huang C, Li J, Hong D, Wang Y . Better surgical treatment method for hepatocellular carcinoma with portal vein tumor thrombus. World J Gastroenterol. 2018; 24(40):4527-4535. PMC: 6209573. DOI: 10.3748/wjg.v24.i40.4527. View

10.

Wu B, Zhang Y, Tan H, Shi H . Value of F-FDG PET/CT in the diagnosis of portal vein tumor thrombus in patients with hepatocellular carcinoma. Abdom Radiol (NY). 2019; 44(7):2430-2435. DOI: 10.1007/s00261-019-01997-2. View

11.

Cerrito L, Annicchiarico B, Iezzi R, Gasbarrini A, Pompili M, Ponziani F . Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers. World J Gastroenterol. 2019; 25(31):4360-4382. PMC: 6710186. DOI: 10.3748/wjg.v25.i31.4360. View

12.

Wei X, Xu J, Li N, Yu Y, Shi J, Guo W . The role of three-dimensional imaging in optimizing diagnosis, classification and surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus. HPB (Oxford). 2016; 18(3):287-95. PMC: 4814596. DOI: 10.1016/j.hpb.2015.10.007. View

13.

Cardarelli-Leite L, Chung J, Klass D, Marquez V, Chou F, Ho S . Ablative Transarterial Radioembolization Improves Survival in Patients with HCC and Portal Vein Tumor Thrombus. Cardiovasc Intervent Radiol. 2020; 43(3):411-422. DOI: 10.1007/s00270-019-02404-5. View

14.

Mizandari M, Ao G, Zhang Y, Feng X, Shen Q, Chen M . Novel percutaneous radiofrequency ablation of portal vein tumor thrombus: safety and feasibility. Cardiovasc Intervent Radiol. 2012; 36(1):245-8. DOI: 10.1007/s00270-012-0451-8. View

15.

Matsumoto J, Kojima T, Hiraguchi E, Abe M . Portal vein tumor thrombus from colorectal cancer with no definite metastatic nodules in liver parenchyma. J Hepatobiliary Pancreat Surg. 2009; 16(5):688-91. DOI: 10.1007/s00534-009-0061-2. View

16.

Liu P, Huo T, Miksad R . Hepatocellular Carcinoma with Portal Vein Tumor Involvement: Best Management Strategies. Semin Liver Dis. 2018; 38(3):242-251. DOI: 10.1055/s-0038-1666805. View

17.

Li N, Wei X, Cheng S . Application of cystoscope in surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus. World J Gastroenterol. 2016; 22(22):5297-300. PMC: 4893478. DOI: 10.3748/wjg.v22.i22.5297. View

18.

Sasaki K, Tomimaru Y, Wada H, Ogawa H, Yamada D, Tomokuni A . [A Case of Surgical Resection of a Liver Metastasis from Colorectal Cancer with a Macroscopic Portal Vein Tumor Thrombus]. Gan To Kagaku Ryoho. 2016; 42(12):1854-6. View

19.

Huang X, Fan X, Zhang R, Jiang S, Yang K, Chen S . Systemic inflammation and portal vein thrombosis in cirrhotic patients with gastroesophageal varices. Eur J Gastroenterol Hepatol. 2019; 32(3):401-405. DOI: 10.1097/MEG.0000000000001526. View

20.

Wang W, Shen J, Wang C, Ren B, Zhu X, Ni C . Safety and Feasibility of Helical I-125 Seed Implants Combined with Transcatheter Arterial Chemoembolization in Hepatocellular Carcinomas with Main Portal Vein Tumor Thrombus. Cardiovasc Intervent Radiol. 2019; 42(10):1420-1428. DOI: 10.1007/s00270-019-02256-z. View